Medicine and Health

The Long Run towards Personalized Therapy in Non-Small-Cell Lung Cancer: Current State and Future Directions

C. Genova

Explore the latest advancements and ongoing challenges in personalized therapy for non-small-cell lung cancer (NSCLC) as discussed by Carlo Genova. This insightful editorial delves into the complexity of NSCLC treatment, including the rise of targeted therapies and the fascinating role of artificial intelligence in enhancing personalized medicine.

00:00

~3 min • Beginner • English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review

K. H. Do, D. T. Le, et al.

Medicine and Health

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

B. Besse, E. Pons-tostivint, et al.

Medicine and Health

Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer

Y. Zeng, C. Hu, et al.

Medicine and Health

Entrectinib in ROS1-positive advanced non-small cell lung cancer: the phase 2/3 BFAST trial

S. Peters, S. M. Gadgeel, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny